Biotech · Private company
Dracen Pharmaceuticals, Inc.
Track this companyFree. Adds Dracen Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- atezolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DRP-104Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)PHASE1 · RECRUITING · started Oct 28, 2026ClinicalTrials.gov NCT07430202 · fetched Nov 12, 2026
- DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 12, 2024ClinicalTrials.gov NCT06027086 · fetched Nov 12, 2026
- Study to Investigate DRP-104 in Adults With Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Aug 31, 2020ClinicalTrials.gov NCT04471415 · fetched Nov 12, 2026